IAG Announce the Acceptance of 2 Abstracts from Clinical Studies in Rheumatoid and Juvenile Rheumatoid Arthritis at EULAR 2017
IAG, Image Analysis Group announces the acceptance of two abstracts from clinical studies in Rheumatoid and Juvenile Rheumatoid Arthritis by the Annual European Congress of Rheumatology organized by the European League Against Rheumatism (EULAR) 2017, held in Madrid from 14-17 June.
Pre and post treatment MRI of a patient with rheumatoid arthritis processed with DYNAMIKA. In colour: map of maximum enhancement showing the most active areas of synovial inflammation in yellow-white and less active – red. Quantitative comparison of the volume and level of inflammation is shown in the bottom left corner. The graphs correspond to the time intensity vs synovial enhancement in the MCP joint selected in the pre and post treatment images.
Following is a list of accepted abstracts:
“Quantification of Dynamic MRI Examinations in Juvenile Idiopathic Arthritis,” N. Tzaribachev, R. Hagoug, P. Louka, J. Islam, M. Hinton, O. Kubassova, M. Boesen, showing that in 18 patients statistically significant and clinically meaningful changes were documented for Dynamic Contrast Enhanced MR Quantification (DEMRIQ) method. In all patients sub-clinical disease could be detected on MRI in clinically unaffected joints. The abstract will be presented as a poster on 17 June 2017 at 10:15 Poster area / Poster session III.
“Dynamic Contrast Enhanced MRI in Randomised Placebo-Controlled Rheumatoid Arthritis Trial – Impact of Applying Joint Coverage Quality Criteria,” M. B. Axelsen, H. Bliddal, L. T. H. Jacobssen, M. S. Hansen, A. Dudek, M. Rell-Bakalarska, M. Boesen, J. Stefanek, B. Sundman-Engberg, M. Østergaard emphasises the importance of standartization of DCE-MRI as an critical imaging endpoint in efficacy trials
The European League Against Rheumatism (EULAR) is the organization which represents the patient, health professional and scientific societies of rheumatology of all the European nations. EULAR endeavors to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. In line with UEMS, EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems.
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: www.ia-grp.com
Reach out: email@example.com
Follow the Company: Linkedin
Join us at BIO International Convention in Boston 5th-8th June 2023
Drug development ideas in osteoarthritis, psoriatic arthritis and scleroderma.
The Invitation-only network for founders &CEOs of the most successful scaleups.